Idiopathic pulmonary fibrosis trials in Chile

5 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis

  Where

  Curicó, Ñuñoa, Santiago, Viña del Mar

  Age

  40 years and over

  People

  324 worldwide

  Run by

  Contineum Therapeutics

  See details and how to joinNCT07284459 · EU 2025-521901-42-00
• Phase 3Not yet taking people in Chile
  Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis

  Where

  Concepción, Curicó, Quillota, Santiago, Talca, Talcahuano, Viña del Mar

  Age

  18 years and over

  People

  2,380 worldwide

  Run by

  Bristol-Myers Squibb

  See details and how to joinNCT07441408 · EU 2025-522373-10-00
• Phase 2Taking people
  A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.

  Where

  Providencia, Santiago, Talca, Viña del Mar

  Age

  40 years and over

  People

  359 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT07652658
• Phase 3Enrolling by invitation
  Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease

  Where

  Quillota, Santiago, Talca

  Age

  40 years and over

  People

  1,850 worldwide

  Run by

  United Therapeutics

  See details and how to joinNCT04905693
• Phase 3Taking people
  Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

  Where

  Curicó, Quillota, Santiago, Viña del Mar

  Age

  18 years and over

  People

  698 worldwide

  Run by

  United Therapeutics

  See details and how to joinNCT05943535 · EU 2023-504904-26-00